Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer
European Journal of Cancer · 2024-03 · 200 · 113560
DOI: 10.1016/j.ejca.2024.113560 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Cancer, 2024-03. Verfasst von Vanita Noronha und 50 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Tata Memorial Centre, HBNI, Mumbai, India. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Mouth Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Tata Memorial Centre, HBNI, Mumbai, India.
- Department of Head and Neck Surgery, Tata Memorial Centre, HBNI, Mumbai, India.
- Section of Biostatistics, Centre for Cancer Epidemiology, Tata Memorial Centre, HBNI, Mumbai, India.
- Department of Radiation Oncology, Tata Memorial Centre, HBNI, Mumbai, India.
- Department of Medical Oncology, Tata Memorial Centre, HBNI, Mumbai, India. Electronic address: kumarprabhashtmh@gmail.com.
Zitieren
APA
Noronha, V., Patil, V., Chaturvedi, P., Mathrudev, V., Menon, N., Bhattacharjee, A., Singh, A., Peelay, Z., Chakraborty, S., Jadhav, M., Alone, M., Bhagyavant, P., Kolkur, M., Srinivas, S., Das, S., Roy, S., Mandal, T., Dsouza, H., Saha, S., …, & Prabhash, K. (2024). Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer. European Journal of Cancer, 200, 113560. https://doi.org/10.1016/j.ejca.2024.113560
Vancouver
Noronha V, Patil V, Chaturvedi P, Mathrudev V, Menon N, Bhattacharjee A, et al. Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer. European Journal of Cancer. 2024;200:113560. doi:10.1016/j.ejca.2024.113560
BibTeX
@article{Noronha2024,
author = {Noronha, Vanita and Patil, Vijay and Chaturvedi, Pankaj and Mathrudev, Vijayalakshmi and Menon, Nandini and Bhattacharjee, Atanu and Singh, Ajay and Peelay, Zoya and Chakraborty, Shatabdi and Jadhav, Monica and Alone, Mitali and Bhagyavant, Priyanka and Kolkur, Manali and Srinivas, Sujay and Das, Sudeep and Roy, Somnath and Mandal, Tanmoy and Dsouza, Hollis and Saha, Saswata and Rai, Rahul and Srikanth, Anne and Shah, Darshit and Khan, Arif and Muthuluri, Hemanth and Kumar, Amit and Agarwal, Amit and Rajpurohit, Anu and Goli, Vasu Babu and Sekar, Anbarasan and Mantri, Anoop and Kanteti, Aditya Pavan Kumar and Majumdar, Swaratika and Khaddar, Satvik and Shenoy, Ramnath and Elamarthi, Prahlad and Rathnasamy, Narmadha and Kashyap, Lakhan and Abraham, George and Booma, Naveen and Simha, Vijay and Chaukar, Devendra and Pai, Prathamesh and Nair, Sudhir and Laskar, Sarbani and Nawale, Kavita and Naidu, Priyanka and Salian, Sushmita and Shelar, Priyanka and Raulo, Ravinarayan and Dhumal, Sachin Babanrao and Prabhash, Kumar},
title = {Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer},
journal = {European Journal of Cancer},
year = {2024},
volume = {200},
pages = {113560},
doi = {10.1016/j.ejca.2024.113560}
}
EUVIMED